Phase 1b evaluation of safety and activity of JK07 in heart failure with reduced ejection fraction

Back

HFA Premium Access

Phase 1b evaluation of safety and activity of JK07 in heart failure with reduced ejection fraction

Session: Late breaking clinical trials: chronic HF and cardiomyopathies

Topic: Pharmacotherapy

Speaker: Professor W. Tang (Cleveland, US)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Professor Wai Hong Wilson Tang

Cleveland Clinic, Cleveland (United States of America)

4 presentations

1 follower

5 more presentations in this session

Remote Hemodynamic Monitoring of Pulmonary Artery Pressures in Patients with Chronic Heart Failure (MONITOR-HF): A randomized controlled clinical trial

Speaker: Professor J. Brugts (Rotterdam, NL)

Access

Slides

Video

TRACER-HF: Trientine-HCL for treatment of heart failure and reduced ejection fraction

Speaker: Professor J. Januzzi (Boston, US)

Access

Slides

Video

REDWOOD-HCM-Cohort 4: Aficamten in non-obstructive HCM

Speaker: Doctor A. Masri (Portland, US)

Access

Slides

Video

Primary results of the Phase Ib proof-of-concept study of NI006, a recombinant human antibody to deplete amyloid deposits in ATTR-cardiomyopathy

Speaker: Doctor P. Garcia-Pavia (Majadahonda, ES)

Access

Slides

Video

Patisiran treatment for ATTR cardiac amyloidosis: 18-month results of the phase 3 APOLLO-B study

Speaker: Professor M. Fontana (London, GB)

Access

Slides

Video

Access the full session

Late breaking clinical trials: chronic HF and cardiomyopathies

Speakers: Professor W. Tang, Professor J. Brugts, Professor J. Januzzi, Doctor A. Masri, Doctor P. Garcia-Pavia...

Access

Video

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources